Jubilant Pharmova Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jubilant Pharmova has informed stock exchanges that its trading window for dealing in company securities is closed from October 1, 2025, until 48 hours after the announcement of financial results for the quarter and half year ending September 30, 2025. This is a standard compliance measure under SEBI's insider trading regulations, and all designated persons have been told not to trade during this period. The date of the board meeting to approve these Q2 and H1 FY26 results has not been disclosed yet and will be communicated later. The filing has been made by Naresh Kapoor, Company Secretary, and posted on the company's website.
This is a routine regulatory filing with no direct impact on the stock price, but it signals that the company's Q2 and H1 FY26 financial results will be announced in the near future, which is the event investors should watch for. Until then, insiders cannot buy or sell the stock, limiting insider activity.